{
    "symbol": "ACB",
    "quarter": 1,
    "year": 2023,
    "date": "2022-11-10 20:48:03",
    "content": " So to wrap my section up, the key drivers for Aurora to reach our positive adjusted EBITDA milestone by the end of this calendar year, starting from our Q1 loss of $8.7 million are as follows: first, we expect revenues to recover in Q2 as the negative impact of certain cultivar supply and wholesale distribution disruptions affecting our European medical and Canadian consumer business units have been resolved, and our non-new international segment revenue returns to normalized levels consistent with that of Q4 2022."
}